Literature DB >> 31880320

Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.

Huijun Huang1,2, Tiejun Qin1, Zefeng Xu1,2, Zhongxun Shi1,2, Bing Li1,2, Lijuan Pan1, Naibo Hu1, Shiqiang Qu1, Gang Huang3, Robert P Gale4, Zhijian Xiao1,2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31880320      PMCID： PMC9204510          DOI： 10.1111/bjh.16326

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  13 in total

Review 1.  Myelodysplasia.

Authors:  M L Heaney; D W Golde
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

Review 2.  Are myelodysplastic syndromes and acute myeloid leukemia one disease?

Authors:  Robert Peter Gale; John M Bennett
Journal:  Leuk Res       Date:  2008-11-08       Impact factor: 3.156

3.  Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape.

Authors:  P Silva; M Neumann; M P Schroeder; S Vosberg; C Schlee; K Isaakidis; J Ortiz-Tanchez; L R Fransecky; T Hartung; S Türkmen; A Graf; S Krebs; H Blum; C Müller-Tidow; C Thiede; G Ehninger; H Serve; J Hecht; W E Berdel; P A Greif; C Röllig; C D Baldus
Journal:  Leukemia       Date:  2017-04-03       Impact factor: 11.528

Review 4.  The contribution of Auer rods to the classification and prognosis of myelodysplastic syndromes.

Authors:  J F Seymour; E H Estey
Journal:  Leuk Lymphoma       Date:  1995-03

5.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Authors:  R Coleman Lindsley; Brenton G Mar; Emanuele Mazzola; Peter V Grauman; Sarah Shareef; Steven L Allen; Arnaud Pigneux; Meir Wetzler; Robert K Stuart; Harry P Erba; Lloyd E Damon; Bayard L Powell; Neal Lindeman; David P Steensma; Martha Wadleigh; Daniel J DeAngelo; Donna Neuberg; Richard M Stone; Benjamin L Ebert
Journal:  Blood       Date:  2014-12-30       Impact factor: 22.113

6.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Authors:  Bruce D Cheson; Peter L Greenberg; John M Bennett; Bob Lowenberg; Pierre W Wijermans; Stephen D Nimer; Antonio Pinto; Miloslav Beran; Theo M de Witte; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Steven D Gore; Charles A Schiffer; Hagop Kantarjian
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

7.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Myelodysplastic syndrome is not merely "preleukemia".

Authors:  Maher Albitar; Taghi Manshouri; Yu Shen; Diane Liu; Miloslav Beran; Hagop M Kantarjian; Anna Rogers; Iman Jilani; Chung Wu Lin; Sherry Pierce; Emil J Freireich; Elihu H Estey
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 10.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113
View more
  1 in total

1.  Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2.

Authors:  Yi Wang; Yaoyao Shen; Jiaqian Qi; Jia Chen; Yang Xu; Feng Chen; Xiao Ma; Miao Miao; Shengli Xue; Huiying Qiu; Xiaowen Tang; Yue Han; Suning Chen; Aining Sun; Yanming Zhang; Depei Wu; Ying Wang
Journal:  Ann Hematol       Date:  2022-03-02       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.